Comments on: Life sciences briefing: Thursday, Feb. 14, 2008

By: Three yards and a cloud of dust: Bioheart makes it across the IPO goal line, but with little to show for its struggles » VentureBeat

Wed, 20 Feb 2008 04:27:01 +0000

[...] of the opportunity to tout Bioheart in our comments section. (Leonhardt’s comment appears here; Farley’s is here.) I say “apparently” because I don’t have independent [...]

By: Levitation option still valid for Wile E. Coyote » VentureBeat

Levitation option still valid for Wile E. Coyote » VentureBeat — Thu, 14 Feb 2008 22:55:39 +0000

[...] gone down in flames so far this year. An eighth startup, robotic-surgery maker MAKO Surgical, just slashed its offering price. For more stories on VentureBeat Life Sciences, click here.Tagged IPO, IPO withdrawal, life [...]

By: Howard J. Leonhardt

Howard J. Leonhardt — Thu, 14 Feb 2008 20:48:20 +0000

Raising $63.8 million is a great accomplishment! MAKO is another South Florida Biosciences success story! Home of Cordis, World Medical, Bolton and Bioheart, Inc. other great life science companies. The University of Miami recently recruited Dr. Pascal Goldschmidt from Duke, Dr. Joshua Hare from Johns Hopkins, Dr. William O’Neill from Willima Beumont Detroit and Dr. Juan Parodi from Washington University Hospital St. Louis, MO. South Florida with Scripps and Max Planck is now emerging to be the Life Sciences growth center of the U.S.!